Customize your JAMA Network experience by selecting one or more topics from the list below.
This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
This volume presents not only reports on the medicinal articles which the Council has found unacceptable for inclusion in New and Nonofficial Remedies during the past year but also status reports on therapeutic advances and procedures and on promising drugs.
Widespread attention was attracted by publication in The Journal of the report of Dr. S. M. Feinberg, "Histamine and Antihistaminic Agents," sponsored by the Council, which appears in this volume. Since it was first published the Council has accepted for inclusion in New and Nonofficial Remedies the two new agents evaluated in the article, diphenhydramine hydrochloride and tripelennamine hydrochloride ("benadryl hydrochloride" and "pyribenzamine hydrochloride," respectively).
During the past year the Council has reported on three unacceptable preparations: Cabasil, an unscientific mixture, the exploitation of which for use in a multitude of disease conditions is aptly expressed in the title, "Quackery Unlimited"; the pseudoscientific ethylene disulphonate (Allergosil brand), a preparation of
Annual Reprint of the Reports of the Council on Pharmacy and Chemistry of the American Medical Association for 1946, with the Comments that Have Appeared in the Journal. JAMA. 1948;136(3):213. doi:10.1001/jama.1948.02890200067028
Coronavirus Resource Center
Create a personal account or sign in to: